Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Quality Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Quality Index of 1.66x as of September 2025. Operating cash flow of CN¥21.03 Million exceeds net income of CN¥12.65 Million, indicating high earnings quality where cash backs reported profits. Also explore 688091 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Yizhong Pharmaceutical Co Ltd (688091) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year earnings quality comparison for Shanghai Yizhong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 688091 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 5.65x | CN¥39.44 Million | CN¥6.98 Million | ▲ +955.3% |
| 2023 | 0.54x | CN¥86.55 Million | CN¥161.55 Million | ▼ -30.9% |
| 2022 | 0.78x | CN¥110.78 Million | CN¥142.85 Million | — |